Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Urology|January 23, 2009
Urodynamic measurements by radiotelemetry in conscious, freely moving beagle dogsGerald P McCafferty, Robert W Coatney, Nicholas J Laping, et al.
British Journal of Pharmacology|March 21, 2006
Dual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female catAlexandra Wibberley, Gerald P McCafferty, Christopher Evans, et al.
American Journal of Physiology. Renal Physiology|May 30, 2008
Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout miceGerald P McCafferty, Blake A Misajet, Nicholas J Laping, et al.
Pharmacology|July 30, 2003
Effect of endothelin on bladder contraction: potential role in bladder hyperactivityTimothy D Westfall, Gerald P McCafferty, Mark Pullen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Characterization of neuromedin U effects in canine smooth muscleTimothy D Westfall, Gerald P McCafferty, Mark Pullen, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2007
GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dogAlexandra Hicks, Gerald P McCafferty, Erin Riedel, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 31, 2007
Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the ratGerald P McCafferty, Mark A Pullen, Charlene Wu, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
The discovery of GSK221149A: a potent and selective oxytocin antagonistJohn Liddle, Michael J Allen, Alan D Borthwick, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2008
N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part IKevin S Thorneloe, Anthony C Sulpizio, Zuojun Lin, et al.
Pageof 1